Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001601830-25-000140
Filing Date
2025-08-29
Accepted
2025-08-29 16:26:37
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B7 rxrx-prospectussupplement2.htm 424B7 396934
2 exfilingfees.htm   iXBRL EX-FILING FEES 24394
3 image_1.jpg GRAPHIC 3866
4 image_4.jpg GRAPHIC 144
5 image_9.jpg GRAPHIC 10256
  Complete submission text file 0001601830-25-000140.txt   562682

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4829
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-284878 | Film No.: 251281274
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)